Takeda Pharmaceutical Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TAK research report →
About the company
Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. The company's operations extend across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and numerous other Asian and worldwide markets. Its extensive portfolio of medicines targets critical therapeutic areas, including digestive disorders (gastroenterology), rare diseases, plasma-derived treatments, cancer care (oncology), and neurological conditions.
- CEO
- Christophe Weber
- IPO
- 2010
- Employees
- 49,281
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $49.67B
- P/E
- 41.31
- P/S
- 1.78
- P/B
- 1.02
- EV/EBITDA
- 8.69
- Div Yield
- 3.94%
- Gross Margin
- 58.76%
- Op Margin
- 10.54%
- Net Margin
- 4.26%
- ROE
- 2.61%
- ROIC
- 2.59%
- Revenue
- $4.78T · 4.28%
- Net Income
- $203.33B · 88.39%
- EPS
- $63.91 · 87.01%
- Op Income
- $573.04B
- FCF YoY
- -5.57%
- 52W High
- $18.90
- 52W Low
- $12.99
- 50D MA
- $16.89
- 200D MA
- $15.99
- Beta
- 0.09
- Avg Volume
- 3.05M
Get TickerSpark's AI analysis on TAK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 27, 26 | Smoter Jennifer Marie | other | 0 |
| Apr 27, 26 | Weber Christophe Pierre | other | 78,900 |
| Apr 27, 26 | Weber Christophe Pierre | other | 165,370 |
| Apr 27, 26 | Weber Christophe Pierre | other | 78,978 |
| Apr 27, 26 | Furuta Milano | other | 7,800 |
| Apr 27, 26 | Furuta Milano | other | 7,814 |
| Apr 27, 26 | Plump Andrew Stewart | other | 212,470 |
| Apr 27, 26 | Ricci Gabriele | other | 34,994 |
| Apr 27, 26 | Bitetti Teresa Marie | other | 64,988 |
| Apr 27, 26 | Duprey Lauren Rusckowski | other | 59,990 |
Our TAK coverage
Recent articles, reports, and earnings notes.
No research on TAK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TAK report →Similar companies
Peers in the same neighborhood.